Target type: biologicalprocess
The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating. [GOC:go_curators]
Cardioblast differentiation is a complex process that begins with the commitment of multipotent mesoderm progenitors to the cardiomyocyte lineage. This involves a cascade of transcriptional and signaling events, leading to the emergence of specialized cells that form the heart muscle.
The process starts with the expression of key transcription factors like GATA4, NKX2-5, and MEF2C in mesoderm progenitors. These factors act as master regulators, initiating a program of gene expression that defines the cardiomyocyte fate.
Simultaneously, signaling pathways like Wnt, BMP, and Notch become active, further influencing cell fate decisions and promoting cardioblast differentiation.
The differentiation process is characterized by a series of morphological changes. Cardioblasts undergo extensive proliferation and acquire a characteristic elongated shape. They also begin to express contractile proteins like myosin and actin, preparing them for the rhythmic contractions that drive the heartbeat.
As cardioblasts mature, they form organized structures called myofibrils, which are composed of sarcomeres, the functional units of muscle contraction. This process requires precise coordination of cytoskeletal remodeling and protein assembly.
Furthermore, cardioblasts establish gap junctions, specialized cell-cell contacts that allow for synchronized electrical activity and coordinated contraction of the heart muscle.
Finally, cardioblasts undergo terminal differentiation, acquiring the full functional capacity of mature cardiomyocytes, including the ability to generate action potentials and contract in response to electrical signals.
This intricate process of cardioblast differentiation is tightly regulated by a complex interplay of genetic and environmental factors. It ensures the development of a functional heart, a crucial organ for maintaining life.'
"
Protein | Definition | Taxonomy |
---|---|---|
EEF1AKMT4-ECE2 readthrough transcript protein | An EEF1AKMT4-ECE2 readthrough transcript protein that is encoded in the genome of human. [PRO:DAN, UniProtKB:P0DPD8] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
thiorphan | Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms. | N-acyl-amino acid | |
captopril | captopril : A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug. Captopril: A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. | alkanethiol; L-proline derivative; N-acylpyrrolidine; pyrrolidinemonocarboxylic acid | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
kelatorphan | kelatorphan: inhibitor of enkephalin metabolism; structure given in first source | ||
retrothiorphan | retrothiorphan: RETRO-THIORPHAN was an EN to THIORPHAN 1989-93 | ||
phosphoramidon | phosphoramidon : A dipeptide isolated from the cultures of Streptomyces tanashiensis. phosphoramidon: a membrane metallo-endopeptidase & endothelin-converting enzyme inhibitor; thermolysin inhibitor from culture filtrate of Streptomyces tanashiensis; structure | deoxyaldohexose phosphate; dipeptide | bacterial metabolite; EC 3.4.24.11 (neprilysin) inhibitor; EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor |